Vaccines Archive — Page 8 of 14
-
December 10, 2020
Exploiting viral vulnerabilities
The isolation of human monoclonal antibodies against dangerous viruses including EEEV, Hendra and Nipah could offer new ways to treat and prevent these infections. -
December 1, 2020
Vanderbilt University Medical Center’s Crowe receives 2020 “Golden Goose” Award for COVID-19 research
James Crowe Jr., MD, a physician-scientist at Vanderbilt University Medical Center who has pioneered development of human monoclonal antibodies as potential treatments for viral diseases, has won a 2020 “Golden Goose” Award. -
November 2, 2020
VUMC begins study of second COVID-19 vaccine
Vanderbilt University Medical Center has begun recruiting up to 250 participants for a Phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. -
October 13, 2020
COVID-19 long-acting antibodies discovered by Vanderbilt University Medical Center move to phase 3 clinical trials
AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca. -
September 22, 2020
Rational vaccine design
Understanding immunity generated by smallpox vaccine may hold lessons for COVID-19 vaccine development. -
August 17, 2020
‘DNA’ zooms up charts in 1st week; hear ‘Vaccines’ episode
Vanderbilt University Medical Center’s original podcast series, Vanderbilt Health DNA, rocketed to the top of the podcast charts in science, health and medicine in the first week since its launch. -
August 10, 2020
Occupational Health invites you to name this year’s flu vaccine campaign
In 2011 Vanderbilt University Medical Center received worldwide attention for doubling the Guinness World Record for the number of flu shots given in an 8-hour period, making its annual flu vaccine event, Flulapalooza, a model for others to follow.